Despite significant progress, malaria remains a major public health concern in Kenya. With evolving mosquito patterns and early signs of insecticide resistance emerging in some regions, the country recognized that bold, preventive action was needed.

​

The Ministry of Health developed Kenya’s Multiple First-Line Therapies (MFT) Implementation Plan (2026–2030) with the Unitaid-funded STOP-AMDR project. Implemented by Jhpiego, STOP-AMDR provides the technical and financial support that is making bold action possible.

Jhpiego works with Cameroon’s Ministry of Public Health and the National Malaria Control Program (NMCP) to support and supervise the implementation of seasonal malaria chemoprevention (SMC) campaigns in the North and Far North Regions of the country to significantly reduce malaria-related morbidity and mortality.

The four-year, $26.5 million grant will help minimize the impact of antimalarial drug resistance.

Heavy rainfall in Cameroon’s North and Far North Regions is typical during the country’s rainy season, with rain falling nearly…

Malaria is a life-threatening disease spread to humans by certain types of mosquitoes. Predominantly found in tropical countries, it affects…